Pharma: Weight loss injection from employer: This is how companies could reduce absentee days
Manufacturers of weight loss products are hoping that companies will offer their medication as a benefit to employees. Chronic obesity costs the German economy billions due to high absenteeism.
Pharmaceutical companies Lilly and Novo Nordisk, which manufacture weight loss medications, are seeking contracts with German employers to offer their employees free weight loss injections as a benefit. This move comes as they face challenges in getting their medications covered by statutory health insurance in Germany. The companies aim to secure deals before more competitors enter the lucrative weight loss market in 2028.
According to a study, employees with obesity have 13 more days of absence than average, resulting in €3,029 higher annual costs, and experts believe that employers could save significantly by offering weight loss treatments.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
